A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
Recruiting · Phase 2 · NCT06937931
Conditions: Cervical Dystonia
At a glance
- Research payments reported, 2025
- $363,581
- U.S. investigators named
- 8
- Sites paid
- 13
- Planned or actual enrollment
- 132
About the trial
- Sponsor
- Ipsen
- Tested
- Corabotase (biological), Placebo (other)
- Dates
- Started 2025-06-30; completion 2027-11-05
- Results posted
- Not yet
The purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain and stiffness, and headaches. CD is believed to involve deep parts within the brain that control movement, but genetic factors, environmental factors, and abnormalities in the brain may also play a role. The usual treatment for CD includes injecting BoNT into the affected muscles, but the treatment only lasts about 3 months. Corabotase is designed to last for a longer …
From ClinicalTrials.gov, last updated 2026-09-08. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Ipsen Innovation reported $363,581 in research payments for this study in 2025 (119 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Scott J. Sherman, MD Neurology · Tucson, AZ
- Daniel D. Truong, M.D. Neurology · Fountain Valley, CA
- Robert Hauser, MD Neurology · Tampa, FL
- Stuart H. Isaacson, MD Neurology · Boca Raton, FL
- Hyder Jinnah, MD PHD Neurology · Atlanta, GA
- Aaron L. Ellenbogen, D.O. Neurology · Farmington Hills, MI
- Winona Tse, M.D. Neurology · New York, NY
- David R. Greeley, MD Neurology · Spokane, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Emory University Hospital, GA $99,490
- Accel Research Sites $66,217
- Biomedical Research Alliance of New York $56,632
- Parkinsons Disease and Movement Disorders Center of Boca Raton $37,409
- Parkinsons and Movement Disorder Institute $35,623
- University of South Florida Health $24,415
- Emory Brain Health Center $13,379
- Usf Health Byrd Alzheimers Institute $7,986
- Kingfisher Cooperative, Llc $6,876
- Icahn School of Medcne Mt Sinai $5,113
- Quest Research Institute $3,735
- $3,650
- University of Arizona College of Medicine $3,013
- The Truong Neuroscience Institute $44
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.